Actively Recruiting
Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
Led by Changzhou No.2 People's Hospital · Updated on 2025-05-14
300
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The patients with vitreous floaters were randomly divided into to groups after excluding the possibility of coexisting ocular pathologies potentially confounding visual symptoms or vitreoretinal anatomy. The control group performed conventional oral education. The experimental group conducted multimedia health education activities on the basis of conventional oral education. Their VRQoL (Visual Function Questionnaire-25, VFQ-25) and anxiety status (State-Trait Anxiety Inventory, STAI) were evaluated before education and at the final follow-up. The demographic and clinical characteristics (gender, age, eduaction, duration of vitreous floaters, comorbidities and so on) were collected.
CONDITIONS
Official Title
Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of vitreous floaters
- Ability to complete questionnaires
You will not qualify if you...
- Secondary vitreous floaters requiring surgical intervention
- Other eye diseases affecting vitreoretinal anatomy
- History of vitreoretinal surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
the Second People's Hospital of Changzhou
Changzhou, Jiangsu, China, 213100
Actively Recruiting
Research Team
Q
Qing Feng
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here